Turn Therapeutics (TTRX) Accumulated Expenses (2024 - 2026)

Turn Therapeutics' Accumulated Expenses history runs 3 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• On a quarterly basis, Accumulated Expenses changed N/A year-over-year to $2.3 million in Q1 2026; TTM through Mar 2026 was $2.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.9 million, up 338.91% from the prior year.
• Accumulated Expenses fell to $2.3 million in Q1 2026 per TTRX's latest filing, from $2.9 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $2.9 million in Q4 2025 and bottomed at $667272.0 in Q4 2024.
• The 3-year median for Accumulated Expenses is $2.3 million (2025), against an average of $2.0 million.
• Biggest YoY gain for Accumulated Expenses was 338.91% in 2025; the steepest drop was 338.91% in 2025.
• Year by year, Accumulated Expenses stood at $667272.0 in 2024, then surged by 338.91% to $2.9 million in 2025, then decreased by 20.95% to $2.3 million in 2026.
• Per Business Quant, the three latest TTRX Accumulated Expenses figures stand at $2.3 million (Q1 2026), $2.9 million (Q4 2025), and $2.3 million (Q3 2025).